Azenta, Inc. (AZTA) to Sell B Medical Systems, Appoints Lawrence Y. Lin as CFO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Azenta, Inc. (AZTA) PT Lowered to $48 at Evercore ISI
November 13, 2024 5:43 AM ESTEvercore ISI analyst Vijay Kumar lowered the price target on Azenta, Inc. (NASDAQ: AZTA) to $48.00 (from $50.00) while maintaining a In Line rating.
The analyst comments 4Q Results: AZTAs org revs declined -2%, with total revs of $170 MM inline with ST. SMS... More
Azenta, Inc. (AZTA) Tops Q4 EPS by 8c
November 12, 2024 4:11 PM ESTAzenta, Inc. (NASDAQ: AZTA) reported Q4 EPS of $0.18, $0.08 better than the analyst estimate of $0.10. Revenue for the quarter came in at $170 million versus the consensus estimate of $169.61 million.
For earnings history and earnings-related data on Azenta, Inc. (AZTA) click here.
... More